Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11120594rdf:typepubmed:Citationlld:pubmed
pubmed-article:11120594lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:11120594lifeskim:mentionsumls-concept:C0028351lld:lifeskim
pubmed-article:11120594lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:11120594lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:11120594lifeskim:mentionsumls-concept:C1327413lld:lifeskim
pubmed-article:11120594lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:11120594pubmed:issue4lld:pubmed
pubmed-article:11120594pubmed:dateCreated2001-1-26lld:pubmed
pubmed-article:11120594pubmed:abstractTextWe recently showed that clones of Th1 cells, but not Th2 cells, expressed a functional beta-2-adrenergic receptor (beta2AR) and that either norepinephrine or the beta2AR agonist terbutaline stimulated this receptor to modulate the level of Th1 cytokines produced. In the present study, we show that norepinephrine and terbutaline stimulate the beta2AR to decrease the level of IL-2 produced by freshly isolated murine splenic naive CD4+ T cells from either Balb/C or DO11.10 transgenic mice and activated polyclonally with anti-CD3 and anti-CD28 mAbs. In contrast, the level of cytokines produced by primary effector Th1 and Th2 cells were unaffected when norepinephrine, terbutaline, or cAMP analogs were added at the time of restimulation. These results suggest that a diversity exists among CD4+ T-cell subsets with respect to the level of adrenergic receptor expression, responsiveness to cAMP, stage of cell differentiation, or a combination of the above.lld:pubmed
pubmed-article:11120594pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:languageenglld:pubmed
pubmed-article:11120594pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:citationSubsetIMlld:pubmed
pubmed-article:11120594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120594pubmed:statusMEDLINElld:pubmed
pubmed-article:11120594pubmed:monthDeclld:pubmed
pubmed-article:11120594pubmed:issn0889-1591lld:pubmed
pubmed-article:11120594pubmed:authorpubmed-author:LeeW TWTlld:pubmed
pubmed-article:11120594pubmed:authorpubmed-author:SandersV MVMlld:pubmed
pubmed-article:11120594pubmed:authorpubmed-author:SwansonM AMAlld:pubmed
pubmed-article:11120594pubmed:authorpubmed-author:Ramer-QuinnD...lld:pubmed
pubmed-article:11120594pubmed:issnTypePrintlld:pubmed
pubmed-article:11120594pubmed:volume14lld:pubmed
pubmed-article:11120594pubmed:ownerNLMlld:pubmed
pubmed-article:11120594pubmed:authorsCompleteYlld:pubmed
pubmed-article:11120594pubmed:pagination239-55lld:pubmed
pubmed-article:11120594pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:meshHeadingpubmed-meshheading:11120594...lld:pubmed
pubmed-article:11120594pubmed:year2000lld:pubmed
pubmed-article:11120594pubmed:articleTitleCytokine production by naive and primary effector CD4+ T cells exposed to norepinephrine.lld:pubmed
pubmed-article:11120594pubmed:affiliationDepartment of Cell Biology, Neurobiology and Anatomy, Loyola University Medical Center, 2160 South First Avenue, Maywood, Illinois 60153, USA.lld:pubmed
pubmed-article:11120594pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11120594pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11120594pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120594lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120594lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120594lld:pubmed